Cargando…
A Novel Treatment for Neurotrophic Corneal Ulcer Using Topical Cenegermin (OXERVATE™) Containing Recombinant Human Nerve Growth Factor
Neurotrophic keratitis represents a complex degeneration of the cornea that can result in debilitating symptoms and serious sight-threatening complications. Patients with neurotrophic keratitis (NK) usually present with a history of corneal injury or past surgical intervention involving damage to th...
Autores principales: | Ahuja, Abhimanyu S, Bowden, Frank W, Robben, Jerry L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772152/ https://www.ncbi.nlm.nih.gov/pubmed/33391953 http://dx.doi.org/10.7759/cureus.11724 |
Ejemplares similares
-
Matrix Regenerating Agent (RGTA) in a Neurotrophic Corneal Ulcer
por: Pereira, Sara, et al.
Publicado: (2020) -
Topical human recombinant nerve growth factor for stage 1 Neurotrophic Keratitis: Retrospective case series of cenegermin treatment
por: Epitropoulos, Alice T., et al.
Publicado: (2022) -
Eight months follow-up of corneal nerves and sensitivity after treatment with cenegermin for neurotrophic keratopathy
por: Pedrotti, Emilio, et al.
Publicado: (2022) -
Neurotrophic Keratopathy Treated with Topical Recombinant Human Nerve Growth Factor (Cenegermin): Case Series Study with Long-Term Follow-Up
por: García-Delpech, Salvador, et al.
Publicado: (2022) -
Neurotrophic keratopathy: Clinical presentation and effects of cenegermin
por: Bu, Julia Bing, et al.
Publicado: (2022)